Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss ... Read More
Pfizer partners with PostEra to speed up drug discovery using machine learning technology
In an exciting new development, Pfizer has teamed up with PostEra, a leading biotech company specializing in machine learning solutions for preclinical drug discovery, to ... Read More
Chinese biotech company InventisBio raises $147m in Series D round
InventisBio, a Chinese biotech company focused on small molecule drugs, has raised $147 million in a Series D funding round. The funding round of the ... Read More
Antoxerene and Juvenescence launch FoxBio to develop anti-aging drugs
Antoxerene, a pharmaceutical company dedicated to developing senolytic drugs, has partnered with investment firm Juvenescence to form a joint venture named FoxBio. This new entity ... Read More